Half-year report · Q2
7133.TEDINET S100UP3P
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥8.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Operating income | ¥449m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥435m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥717m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥435m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥291m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥441m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥291m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥6.9bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥6.4bn | at 2024-03-31 | Cons. | Assets |
| Total liabilities | ¥5.0bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2024-03-31 | Cons. | Net assets |
| Cash and deposits | ¥889m | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥688m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥889m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥688m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥188m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥707m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥188m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥201m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥539m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥41.03 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.05 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.62 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥59.26 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 28.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.9% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 19
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥420,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥420,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥296m |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥277m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥544m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥544m |
| jpcrp040300-q2r_E37198-000Kirari Primereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥338m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥759m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥759m |
| jpcrp040300-q2r_E37198-000Primary Care Homereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥134m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥749m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥745m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 331
| Item | Context | Value | Unit |
|---|---|---|---|
| Name major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)別府 鵬飛 | |
| Address major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)福岡県福岡市中央区 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)ＨＹＵＧＡ ＰＲＩＭＡＲＹＣＡＲＥ株式会社 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)福岡県春日市春日原北町二丁目２番１号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that information is not prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |